Afuco™ Anti-FAP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-211)

Customer Review

There are currently no Customer reviews or questions for AFC-TAB-211. Click the button above to contact us or submit your feedback about this product.

Q&As

1. What methods can I employ to optimize antibody-antigen binding?

   A: Optimize incubation times and temperatures, and ensure proper sample preparation. Blocking and washing steps should also be fine-tuned.

2. Are there known limitations to using this antibody?

   A: Check the datasheet for any known limitations, such as non-reactivity with certain species or incompatibility with specific detection methods.

3. How do I minimize proteolytic degradation of my samples?

   A: Use protease inhibitors in your lysis buffer and keep samples cold during processing to minimize degradation.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Biosimilar Overview

Please refer to Sibrotuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Sibrotuzumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Sibrotuzumab"

DrugMonitor™ Anti-Sibrotuzumab Antibody (VS-1224-YC1086)

Sibrotuzumab is a humanized monoclonal antibody targeting fibroblast activation protein (FAP), used for cancer treatment. The DrugMonitor™ Anti-Sibrotuzumab Antibody (VS-1224-YC1086) is an anti-drug antibody (ADA) against Sibrotuzumab. This drug-based antibody is raised in mice immunized with the Sibrotuzumab. The anti-Sibrotuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Sibrotuzumab in samples.

See other products for "Fap"

Select a product category from the dropdown menu below to view related products.

Humanized Antibodies Human Antibodies Low- or Non-fucosylated Oligosaccharide Antibodies Fc Glycosylation Antibodies IgG Antibodies ScFv Antibodies Fab Antibodies Single Domain Antibodies MHC Tetramers for Cancer Antibody Magnetic Beads ScFv-Fc Chimeras IHC Kits & Antibodies FC Reagents & Kits